Reaction

Blood Immunoglobulin E Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,405 reports · 86 co-occurring drugs

As of the last recalculation, Blood Immunoglobulin E Increased appears in 2,405 FAERS reports alongside 86 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 191.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ciclesonide	268	191.5	195.4
Omalizumab	819	125.6	126.8
Mepolizumab	316	63.2	63.6
Fluticasone Furoate	73	53.8	54.1
Montelukast Sodium	554	50.9	51.1
Fluticasone Propionate And Salmeterol Xinafoate	291	47.6	47.8
Travoprost	44	44.8	45.0
Budesonide And Formoterol Fumarate Dihydrate	362	37.8	38.0
Tiotropium Bromide	480	37.6	37.8
Goserelin	52	34.2	34.4
Budesonide	208	33.4	33.5
Montelukast	270	31.2	31.3
Cetirizine Hydrochloride Allergy	104	31.0	31.1
Cetirizine Hydrochloride Tablets	104	31.0	31.1
Tiotropium Bromide Inhalation Spray	39	30.6	30.7
Albuterol Sulfate	731	30.2	30.3
Bicalutamide	50	29.0	29.1
Salmeterol Xinafoate	28	28.4	28.5
Theophylline	35	26.7	26.8
Theophylline Anhydrous	37	26.2	26.3
Ipratropium Bromide	91	22.9	23.0
Fluticasone Furoate And Vilanterol Trifenatate	84	20.9	21.0
Cetirizine	173	20.7	20.8
Rosuvastatin Calcium	63	19.9	19.9
Itraconazole	26	19.5	19.5
Benralizumab	42	18.5	18.5
Sodium Bicarbonate	48	18.2	18.2
Sodium Bicarbonate Injection,	48	18.2	18.2
Umeclidinium	18	17.5	17.6
Albuterol	219	17.3	17.3
Canagliflozin	56	16.6	16.6
Cetiirizine	76	16.0	16.0
Desloratadine	17	13.8	13.8
Valacyclovir Hydrochloride	105	13.4	13.5
Prednisone	585	13.0	13.0
Cetirizine Hydrochloride	201	11.4	11.4
Fesoterodine Fumarate	14	11.2	11.3
Nicotine Polacrilex Mini	19	11.0	11.1
Nicotine Polarilex	19	11.0	11.1
Calcium Gluconate	15	10.8	10.8
Agalsidase Beta	11	10.3	10.4
Fluticasone Propionate	145	10.2	10.2
Mometasone Furoate And Formoterol Fumarate Dihydrate	18	10.1	10.1
Fluticasone Propionate Nasal	33	9.5	9.5
Ketoconazole Foam	16	9.4	9.4
Ketoconazole Cream, 2%	16	9.4	9.4
Sucralfate Oral	15	9.2	9.2
Sucralfate Oral Suspension	15	9.2	9.2
Doxepin Hydrochloride	13	9.0	9.0
Telmisartan	18	8.8	8.8
Esomeprazole Magnesium Capsule, Delayed Release	14	8.4	8.4
Esomeprazole Magnesium Delayed Release Capsules	14	8.4	8.4
Esomeprazole Magnesium Dihydrate	14	8.4	8.4
Mometasone Furoate	39	8.2	8.2
Antacid	44	8.1	8.2
Ketoconazole	16	8.0	8.1
Voriconazole Injection	20	8.0	8.0
Hydroxyzine	43	7.9	7.9
Irbesartan	39	7.7	7.7
Venlafaxine	62	7.7	7.7
Dornase Alfa	17	7.5	7.6
Alendronate Sodium Tablet	16	7.5	7.5
Empagliflozin	57	7.5	7.5
Azithromycin	34	7.4	7.4
Azithromycin Monohydrate	34	7.2	7.2
Abacavir Sulfate	8	7.1	7.1
Candesartan	29	7.1	7.1
Rabeprazole	18	7.1	7.1
Epinephrine	52	7.0	7.0
Doxepin	8	6.9	6.9
Chlorthalidone	9	6.7	6.7
Mometasone	14	6.6	6.6
Voriconazole	21	6.0	6.0
Desoximetasone	13	5.9	5.9
Golimumab	56	5.8	5.8
Linagliptin	11	5.2	5.2
Dexlansoprazole	25	5.2	5.2
Zidovudine	8	5.2	5.2
Tobramycin	13	4.7	4.7
Rocuronium Bromide	6	4.4	4.4
Guanfacine	4	4.4	4.4
Nicotine Polacrilex	19	4.3	4.3
Nicotine	20	4.3	4.3
Brinzolamide	4	4.0	4.0
Avapritinib	4	2.9	2.9
Dupilumab	64	1.2	1.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.